Therapeutics: Metabotropic glutamate receptor subtype 5 (mGluR5; GRM5)

Neurology

INDICATION: Alzheimer's disease (AD)

Mouse studies suggest mGluR5 antagonists could help treat AD. In two

Read the full 147 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE